¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"leprosy control program"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® leprosy ÇÑ±Û ³ªº´
¼³¸í   
  ³ª±Õ¿¡ ÀÇÇÏ¿© °¨¿°µÇ´Â ¸¸¼º Àü¿°¼º ³­Ä¡º´. ÇǺο¡ »ìÁ¡ÀÌ ºÒ°ÅÁ® ³ª¿À°Å³ª ¹ÝÁ¡ °°Àº °ÍÀÌ »ý±â°í ±× ºÎºÐÀÇ Áö°¢ÀÌ ¸¶ºñµÇ¸ç ´«½çÀÌ ºüÁö°í ¼Õ¹ßÀ̳ª ¾ó±¼ÀÌ º¯ÇüµÇ¸ç ´«ÀÌ Àß º¸ÀÌÁö ¾Ê°Ô µÈ´Ù. ³ªº´Àº È£»ê¼º ¸·´ë±ÕÀΠ³ª±Õ¿¡ ÀÇÇÑ ¸¸¼º Àü¿°º´À¸·Î, ÁַΠÇǺο͠¸»ÃʽŰæÀ» Ä§¹üÇϴ º´ÀÌ´Ù. ´ëºÎºÐÀÌ Àεµ¿¡¼­ ¹ß°ßµÇÁö¸¸ ¿ì¸®³ª¶ó¿¡µµ Àִ º´ÀÌ´Ù. º´Çü ºÐ·ù·Î¼­, ³ªº´Á¾Çü, °áÇÙ³ªº´, °æ°è³ªº´ ±×¸®°í ºÎÁ¤³ªº´ÀÌ ÀÖ´Ù. °¨¿°Àº °í¸§, Ä๰, Ä§¿¡ Á÷Á¢ Á¢ÇÑ °æ¿ì¿¡ ³ªÅ¸³­´Ù. Áõ»óÀº ³ªº´Á¾ÇüÀº °áÀý, Ä§À±, È«¹Ý, Å»¸ðÀÌ°í °áÇÙ³ªº´ÇüÀº °æ°è°¡ ¸íÈ®ÇÑ È«¹Ý, ½Å°æÁõ»óÀ¸·Î¼­ Áö°¢ÀÌ»ó, ½Å°æºñÈÄ, ¶¡³²Àå¾Ö, ÆÈ´Ù¸®ÀÇ º¯ÇüÀÌ ÀϾ´Ù. ÀԾȿµ¿ª¿¡¼­´Â Çô, ÀÔ¼ú, ÀÕ¸ô¿¡ °áÀý¼º È«¹ÝÀ» ¾à 20% º¼ ¼ö ÀÖ´Ù. 
¿µ¹® quality control ÇÑ±Û Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
¼³¸í   
  °úÇÐÀû ¿ø¸®¸¦ ÀÀ¿ëÇÏ¿© Á¦Ç°Ç°ÁúÀÇ À¯Áö-Çâ»óÀ» ±âÇϱâ À§ÇÑ °ü¸®. ³ÐÀº ¶æÀ¸·Î´Â °¡Àå ½ÃÀ强ÀÌ ³ôÀº Á¦Ç°À» °¡Àå °æÁ¦ÀûÀ¸·Î »ý»êÇϱâ À§ÇÑ ÀÏ·ÃÀǠü°ÔÀû Á¶Ä¡¸¦ °¡¸®Å°³ª, ÀϹÝÀûÀ¸·Î´Â ¾ÕÀÇ Á¼Àº ¶æÀÇ ÇØ¼®ÀÌ Åë¿ëµÈ´Ù. ÃʱâÀÇ QC´Â ÀüÁ¦Ç°¿¡ ´ëÇØ Ä¡¼ö-Áß·®-üÀûÀ̳ª Àç·áÀÇ È­ÇÐÀû ¼ººÐ µîÀ» ÃøÁ¤Çϰí, ±×°ÍÀ» ¹Ì¸® Á¤ÇØ ³õÀº Ç°ÁúÇ¥Áذú ºñ±³ÇÏ¿© ÀûºÎ¸¦ ÆÇÁ¤Çϴ ¹æ¹ýÀÌ ÃëÇØÁ³´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy control program
    ³ªº´°ü¸®»ç¾÷
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quality control program
    Áú°ü¸®ÇÁ·Î±×·¥
  • regional quality control program
    Áö¿ªÁú°ü¸®ÇÁ·Î±×·¥
  • weight control program
    üÁßÁ¶Àý°èȹ
  • borderline leprosy
    °æ°è³ªº´, Áß°£³ªº´
  • indeterminate leprosy
    ºÒÈ®Á¤³ªº´, ºÎÁ¤Çü³ªº´
  • lepromatous leprosy
    ³ªÁ¾Çü³ªº´, ³ªº´Á¾³ªº´
  • leprosy
    ³ªº´
  • multibacillary leprosy
    ´Ù±Õ³ªº´, ±Õ¸¹Àº³ªº´
  • macular leprosy
    ¹ÝÁ¡³ªº´
  • nodular leprosy
    °áÀý³ªº´
  • paucibacillary leprosy
    Èñ±Õ³ªº´, ±ÕÀûÀº³ªº´
  • reactional leprosy
    ¹ÝÀÀ¼º³ªº´
  • community health program
    Áö¿ª»çȸº¸°Ç»ç¾÷
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷
  • dental health program
    ±¸°­º¸°Ç»ç¾÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy
    ³ªº´
  • program
    °èȹ, »ç¾÷, °úÁ¤
  • control
    1. ÅëÁ¦, Á¦¾î, 2. ´ëÁ¶, 3. °ü¸®
  • quality control
    Á¤µµ°ü¸®, ǰÁú°ü¸®, Áú°ü¸®
  • reflex control
    ¹Ý»çÁ¶Àý
  • safety control
    ¾ÈÀü°ü¸®
  • sugar control
    Ç÷´çÁ¶Àý
  • impulse control disorder
    Ãæµ¿Á¶ÀýÀå¾Ö, Ãæµ¿Á¶Àýº´
  • case-control study
    ȯÀÚ´ëÁ¶±º¿¬±¸
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy control program
    ³ªº´°ü¸®»ç¾÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quality control program
    Áú°ü¸®°èȹ
  • regional quality control program
    Áö¿ªÁú°ü¸®ÇÁ·Î±×·¥
  • weight control program
    üÁßÁ¶Àý°èȹ
  • borderline leprosy
    °æ°è³ªº´, Áß°£³ªº´
  • indeterminate leprosy
    ºÎÁ¤³ªº´
  • leprosy
    ³ªº´
  • lepromatous leprosy
    ³ªº´Á¾³ªº´
  • macular leprosy
    ¹Ý»ó³ªº´
  • multibacillary leprosy
    ´Ù±Õ³ªº´
  • nodular leprosy
    °áÀý³ªº´
  • paucibacillary leprosy
    Èñ±Õ³ªº´
  • reactional leprosy
    ¹ÝÀÀ³ªº´
  • tuberculoid leprosy
    °áÇÙ³ªº´
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷
  • community health program
    Áö¿ª»çȸº¸°Ç»ç¾÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • quality control program
    Á¤µµ°ü¸®°èȹ
  • Hansen disease = leprosy
    ÇѼ¾º´, ³ªº´
  • Leprosy
    ³ªº´(ÔýÜ»)
  • health promotion program
    °Ç°­Çâ»ó°èȹ.
  • indeterminate leprosy
    ¹Ì<ºÎ>Á¤³ªº´(Ú±<ÝÕ>ïÒÑÛÜ»).
  • indeterminate leprosy
    ¹Ì<ºÎ>Á¤³ªº´(Ú±<ÝÕ>ïÒÑÛÜ»)
  • predisaster program
    ÀçÇØ¿¹¹æ°èȹ(ËøÌ´ËçËÑË­Ì·).
  • preventive program
    ¿¹¹æ»ç¾÷.
  • quality assurance program
    Á¤µµº¸Áõ°èȹ, Á¤µµ°ü¸®°èȹ
  • rat leprosy
    ÁãÀÇ ³ªº´(¡­ÑÛÜ»)
  • AGC (automatic gain control)
    ÀÚµ¿ °ÔÀÎ Á¶Àý
  • AGC (automatic gain control)
    ÀÚµ¿ (í»ÔÑ) °ÔÀÎ Á¶Àý (ðàï½), À̵æÀÚµ¿Á¶Àý
  • Control system
    Á¶Àý°è(ðàï½Í§)
  • Levey Jennings control chart
    ·¹ºñÁ¦´×½º°ü¸®µµ
  • Westgard quality control test
    ¿þ½ºÆ®°¡µåÁ¤µµ°ü¸®°Ë»ç¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy control program
    ³ª¾ïÁ¦Ã¥(Ë»Ëâ̡̤), ³ª°ü¸®°èȹ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cancer control program
    ¾Ï°ü¸®°èȹ(ËâË´ËöË­Ì·), ¾Ï¿¹¹æ»ç¾÷.
  • quality control program
    Á¤µµ°ü¸®°èȹ
  • regional quality control program
    Áö¿ªº°Á¤µµ°ü¸®ÇÁ·Î±×·¥
  • leprosy control
    ³ª°ü¸®
  • behavior monitoring program
    Çൿ(ÇàÅÂ)°¨½ÃÇÁ·Î±×·¥
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷.
  • committee on in service program
    ½Ç¹«±³À°À§¿øÈ¸(ËàËÎË´ËôËôËôÌ·).
  • committee on in service program
    ½Ç¹«±³À°À§¿øÈ¸(ãùÙâÎçëÀêÍê¬üå).
  • community health program
    Áö¿ª»çȸº¸°Ç»ç¾÷°èȹ(ÊÙËÓ˧Ë×ËâË­Ì·).
  • comprehensive program
    Æ÷°ýÀû °èȹ (ÊÙË­Ì·).
  • dental health program
    ±¸°­º¸°Ç»ç¾÷ (¡­ÞÀåö).
  • exercise program
    ¿îµ¿(ê¡ÔÑ)ÇÁ·Î±×·¥.
  • exercise program
    ¿îµ¿ÇÁ·Î±×·¥.
  • exercise program
    ¿îµ¿ÇÁ·Î±×·¥
  • health promotion program
    °Ç°­Çâ»ó°èȹ.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • insect control
    °ïÃæ±¸Á¦, °ïÃæ¹æÁ¦
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor control
    ¼ö¿ëü Á¦¾î (â¥é»ô÷ ð¤åÙ)
  • acceptor-control ratio
    ¼ö¿ëü Á¦¾îÀ² (â¥é»ô÷ ð¤åÙëÒ)
  • adenylate control hypothesis
    ¾Æµ¥´Ò»ê(ß«)Á¶Àý¼³(ðàï½àã)
  • autogenous control
    ÀÚÀÎÁ¶Àý (í»ì×ðàï½)
  • control
    "´ëÁ¶(ÓßðÎ), Á¶Àý(ðàï½), Á¦¾î(ð¤åÙ)"
  • control analysis
    ´ëÁ¶ ºÐ¼®(ÓßðÎÝÂà°)
  • control strengh
    Á¶Àý °­µµ(ðàï½Ë­Óø)
  • negative control
    À½Á¦¾î(ëäð¤åÙ)
  • negative gene control
    À½À¯ÀüÀÚÁ¦¾î(ëäë¶îîí­ð¤åÙ)
  • positive control
    "°¡Á¶Àý(ʦðàï½), ¾ç¼ºÁ¶Àý(åÕàõðàï½)"
  • positive gene control
    "°¡À¯ÀüÀÚÁ¶Àý(ʦë¶îîí­ðàï½), ¾ç¼ºÀ¯ÀüÀÚÁ¶Àý, (åÕàõë¶îîí­ðàï½)"
  • relaxed control
    ÀÌ¿Ï Á¶Àý(ì¬èÐðàï½)
  • respiratory control
    È£Èí Á¶Àý(ðàï½)
  • respiratory-control index
    È£Èí Á¶Àý Áö¼ö(ò¦â¦)
  • stereopopulation control
    ÀÔü±¸Á¶À̼ºÁúü(Ø¡ô÷ϰðãì¶àõòõô÷) Á¦¾î (ð¤åÙ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy
    ³ª, ³ªº´
  • AGC [=automatic gain control]
    ÀÚµ¿°ÔÀÎÁ¶Àý
  • control
    ´ëÁ¶, Á¶Àý, Á¦¾î, °ü¸®, ±ÔÁ¦, ¹æÁ¦
  • control group
    ´ëÁ¶±º
  • equipment quality control
    ÀåÄ¡ÀÇ ¼º´É°ü¸®
  • pulse control unit
    ¸Æ¹ÚÁ¶Àý´ÜÀ§
  • quality control
    È­Áú°ü¸®, ǰÁú°ü¸®
  • remote control
    ¿ø°ÝÁ¶Á¾, ¿ø°ÝÁ¶ÀÛ
  • time gain control
    ½Ã°£°ÔÀÎÁ¶Àý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ILA insulin-like activity; International Leprosy Association
LL large lymphocyte; lateral leminiscus; left lateral; left leg; left lower; left lung; lepromatous [in...
HELP Hawaii early learning profile; Health Education Library Program; Health Emergency Loan Program; Heal...
BCM B-cell maturation; birth control medication; blood-clotting mechanism effects; body cell mass; body ...
CDC calculated date of confinement; cancer diagnosis center; capillary diffusion capacity; cell division...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LL Lepromatous leprosy
POSCH Program On the Surgical Control Of the Hyperlipidemias
Control control
control group control
ADAP AIDS Drug Assistance Program
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • leprosy control
    ³ª °ü¸®
    °³³ä»ó, ÁÖ¹ÎÀ» ³ª±ÕÀÇ Àü¿°À¸·ÎºÎÅÍ º¸È£ÇÏ´Â ¿¹¹æ °ü¸®¿Í, ³ªÈ¯ÀÚ¸¦ ³ª±ÕÀ¸·ÎºÎÅÍ ¿À´Â À°Ã¼Àû, Á¤½ÅÀû °íÅëÀ» ´ú¾î ÁÖ´Â Áø·á °ü¸®ÀÇ µÎ °¡Áö·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ¨ç ¿¹¹æ °ü¸®´Â Àü¿°¿øÀ» Â÷´ÜÇÏ´Â °ÍÀ» ¸»Çϴµ¥, ³ª ȯÀÚ¸¦ °Ý¸®ÇÔÀ¸·Î½á ³ªº´ÀÇ Àü¿°¿øÀÌ Â÷´ÜµÈ´Ù°í »ý°¢Çß´ø ½Ã´ë¿¡´Â ³ª ȯÀÚ Àü¿øÀ» °Ý¸® ¼ö¿ëÇÏ¿´´Ù. ±×·¯³ª Àüü ³ª ȯÀÚ Áß ±ØÈ÷ ÀϺÎÀÇ ¹Ì°ü¸®ÇÏ¿¡ Àִ ȯÀÚ¸¸ÀÌ Àü¿°¿øÀÌ µÈ´Ù´Â »ç½ÇÀÌ ¹àÇôÁø ¿À´Ã³¯¿¡´Â, ³ª ȯÀÚ·Î È®ÀÎÀÌ µÇ¾î ¾àÁ¦ Åõ¿©°¡ ½ÃÀÛµÈ ÈÄ¿¡´Â Àü¿°¿øÀÌ µÉ ¼ö ¾ø´Ù´Â °á·Ð¿¡ À̸£·¶´Ù. ÀÌ¿¡ µû¶ó ¿À´Ã³¯¿¡´Â ÀÏ¹Ý ÇǺΠÁúȯÀÚ¿Í °°ÀÌ ÀÚÀ¯·ÎÀÌ »ý¾÷¿¡ Á¾»çÇϸç Áø·á¸¦ ¹Þ°í ÀÖ´Ù. ¨è Áø·á °ü¸®´Â Àǻ簡 Á¤È®ÇÑ Áø´Ü°ú º´Çü ºÐ·ù¸¦ ¹ÙÅÁÀ¸·Î ÀûÇÕÇÑ Ã³¹æÀ» ³»¸®°í ȯÀÚ°¡ ¼º½ÇÇÏ°Ô ¾àÀ» º¹¿ëÇÏ´Â °ÍÀÌ´Ù. ¹®Á¦´Â ³ªº´ÀÌ ¸¸¼ºÀûÀ¸·Î °æ°úÇÏ´Â Àå±â ÁúȯÀε¥´Ù Ä¡·áÀÇ ¼º°ú°¡ Áï½Ã ³ªÅ¸³ªÁö ¾ÊÀ¸¹Ç·Î 󹿰ú º¹¾àÀÌ ³ªÅÂÇØÁ® Ä¡·á°¡ ºÒ±ÔÄ¢ÇØÁö°í ¾àÁ¦ ³»¼ºÀ» ¹ßÀü½ÃŰ´Â µ¥ µû¸¥ °ü¸®»óÀÇ ¾î·Á¿òÀÌ ÀÖ´Ù. ³ªº´¿¡ ´ëÇÑ Æí°ßÀ» ¾ø¾Ö°í ±¹¹ÎÀû ÀÌÇØ¿Í Âü¿©¿¡ ÀÇÇØ Á¶±â ¹ß°ß ¹× Ä¡·á¿¡ ÀÓÇÑ´Ù¸é ³ªº´ °ü¸®¸¦ À§ÇÑ Æ¯¼ö ½Ã¼³À̳ª ±â°üÀÌ ÇÊ¿ä¾ø°Ô µÉ °ÍÀÌ´Ù.
  • quality control program
    Á¤µµ °ü¸® °èȹ
  • histoid leprosy
    Á¶Á÷±¸¾ç ³ªº´
  • indeterminate leprosy
    ¹ÌÁ¤ ³ªº´, ºÎÁ¤ ³ªº´
  • lepromatous leprosy
    ³ªÁ¾ ³ª
    ³ªº´Çü Áß¿¡¼­´Â °¡Àå ÁßÁõÇüÀÌ´Ù. ³ª±Õ¿¡ ´ëÇÑ ¼¼Æ÷¼º ¸é¿ªÀÌ ÀúÇϵǰí Àֱ⠶§¹®¿¡ ¿¹ÈÄ´Â ÁÁÁö ¾Ê´Ù. ±ÕÀÇ Áõ½ÄÀº ½ÉÇÏ´Ù.
  • leprosy
    ³ªº´, ³ª
    ÇǺÎ, Á¡¸·, ¸»ÃʽŰæ°è¿¡ ¿©·¯ °¡ÁöÀÇ À°¾ÆÁ¾¾ç º´º¯À» Çü¼ºÇÏ´Â ³ª±Õ¿¡ ÀÇÇØ ÀϾ´Â ¸¸¼ºÀÇ Àü¿°¼º Áúȯ. µÎ °¡Áö Çü
  • leprosy bacillus
    ³ª °£±Õ
    »ç¶÷ ³ª ȯÀÚÀÇ ÇǺΠº´¼Ò µµ¸» Ç¥º»À̳ª ±âŸ º´¸® Àç·á Áß¿¡ ±Õ ´Ù¹ß ¶Ç´Â ÀüÇüÀû ÀÀ±«·Î¼­ ´Ù¼ö ¹ß°ßµÇ´Â ¼¼±Õ.
  • leprosy of the larynx
    ÈĵΠ³ªº´
    le
  • leprosy prevention act
    ³ªº´ ¿¹¹æ¹ý
  • multibacillary leprosy
    ´Ù±Õ ³ªº´
  • mutilating leprosy
    Àý´Ü ³ª
  • nodular leprosy
    °áÀý ³ª
    µ¿ÀǾî=tubercular le
  • rat leprosy
    ÁãÀÇ ³ªº´
  • active exercise program
    Àû±ØÀû ¿îµ¿
  • case finding program
    ȯÀÚ ¹ß°ß °èȹ, ȯÀÚ ¹ß°ß »ç¾÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
civilian health and medical program of the uniformed services See: CHAMPUS.
(12 Dec 1998)
program 1. A formal set of procedures for conducting an activity.
2. An ordered list of instructions directing a computer to carry out a desired sequence of operations required to solve a problem.
(05 Mar 2000)
program development The process of formulating, improving, and expanding educational, managerial, or service-oriented work plans (excluding computer program development).
(12 Dec 1998)
program evaluation Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact.
(12 Dec 1998)
seer program A cancer registry mandated under the national cancer act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the united states. The surveillance, epidemiology, and end results (seer) program is a continuing project of the national cancer institute of the national institutes of health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions.
(12 Dec 1998)
small scale energy loan program (SELP) A low-cost loan and technical assistance program administered by the Oregon Department of Energy.
(05 Dec 1998)
immunization program Organised services to administer immunization procedures in the prevention of various diseases. The programs are made available over a wide range of sites: schools, hospitals, public health agencies, voluntary health agencies, etc. They are administered to an equally wide range of population groups or on various administrative levels: community, municipal, state, national, international.
(12 Dec 1998)
treatment protocol program An FDA initiative to allow terminally ill patients to be given experimental drugs.
(14 Nov 1997)
anaesthetic leprosy A form of leprosy chiefly affecting the nerves, marked by hyperesthesia succeeded by anaesthesia, and by paralysis, ulceration, and various trophic disturbances, terminating in gangrene and mutilation.
Synonym: Danielssen's disease, Danielssen-Boeck disease, dry leprosy, trophoneurotic leprosy.
(05 Mar 2000)
articular leprosy A late stage of anaesthetic leprosy.
Synonym: mutilating leprosy.
(05 Mar 2000)
borderline leprosy A form of leprosy that is very unstable immunologically; the cutaneous nerves frequently present bacilli, but the lepromin test is usually negative; cutaneous lesions are comprised of flat bands or plaques.
Synonym: dimorphous leprosy.
(05 Mar 2000)
macular leprosy A form of tuberculoid leprosy in which the lesions are small, hairless, and dry, and are erythematous in light skin and hypopigmented or copper-coloured in dark skin.
(05 Mar 2000)
Malabar leprosy <medicine> A disease of the skin, in which it become enormously thickened, and is rough, hard, and fissured, like an elephant's hide.
Origin: L, fr. Gr, from, an elephant.
Source: Websters Dictionary
(01 Mar 1998)
rat leprosy A slowly but progressively fatal form of leprosy occurring in rats, caused by Mycobacterium lepraemurium; it appears in two forms, glandular and musculocutaneous; causes induration, alopecia, and eventually ulceration.
Synonym: mouse leprosy, murine leprosy.
(05 Mar 2000)
murine leprosy A slowly but progressively fatal form of leprosy occurring in rats, caused by Mycobacterium lepraemurium; it appears in two forms, glandular and musculocutaneous; causes induration, alopecia, and eventually ulceration.
Synonym: mouse leprosy, murine leprosy.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leprosy
    ¹®µÐº´
  • leprosy
    ³ªº´
  • program
    ÇÁ·Î±×·¥
  • City Service Program
    µµ½Ã ´ë»ó ¹æ¼Û
  • European Recovery Program
    ¹Ì±¹ ±¹¹«Àå°ü MarshallÁ¦¾ÈÀÇ À¯·´ ºÎÈï °èȹ
  • Program Practices
    ÇÁ·Î±×·¥ ÇÁ·¢Æ¼½º(ÇÁ·Î±×·¥ÀÇ »çÀü°Ë¿­)
  • austerity program
    ³»Ç̰èȹ(±¹³» ¼Òºñ ¾ïÁ¦,¼öÃâ Áõ´ë·Î ±¹¹Î °æÁ¦¸¦ °³Á¶ÇÏ·Á´Â °èȹ)
  • continuity program
    °è¼Ó ÁÖ¹®(°í°´ÀÇ ÁßÁö ¿äûÀÌ ¾ø´Â ÇÑ °è¼Ó)
  • heuristic program
    ¹ß°ßÀû ÇÁ·Î±×·¥
  • management training program
    °ü¸®ÀÚ ÈÆ·Ã °èȹ
  • minority program
    Àú½ÃûÀ²ÀÇ ÇÁ·Î
  • program
    ÇÁ·Î±×·¥;Â÷·ÊÇ¥;¿¹Á¤;°èȹ;ÇÁ·Î±×·¥(ó¸® ÀýÂ÷¸¦ Áö½ÃÇÑ °Í);ÇÁ·Î±×·¥(Â÷·Ê)¸¦ Â¥´Ù;°èȹÇÏ´Ù;(ÄÄÇ»ÅÍ¿¡)ÇÁ·Î±×·¥À» ³Ö´Ù(ÁÖ´Ù)
  • program director
    ÇÁ·Î±×·¥ ÆíÁýÀÚ
  • program loading
    ÇÁ·Î±×·¥ ·Îµù
  • program music
    Ç¥Á¦ À½¾Ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á